Dabigatran or warfarin for extended maintenance therapy of venous thromboembolism

被引：0

作者：

Schulman, S. ^{[1
]}

Eriksson, H. ^{[2
]}

Goldhaber, S. Z. ^{[3
]}

Kakkar, A. K. L. ^{[4
,5
]}

Kearon, C. ^{[6
]}

Kvamme, A. M. ^{[7
]}

Mismetti, P. ^{[8
]}

Schellong, S. ^{[9
]}

Schnee, J. ^{[10
]}

机构：

[1] HHS Gen Hosp, Thrombosis Serv, Hamilton, ON, Canada

[2] Sahlgrenska Univ Hosp Oestra, Dept Med, Gothenburg, Sweden

[3] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA

[4] Thrombosis Res Inst, London SW3 6LR, England

[5] Queen Mary Univ London, London, England

[6] McMaster Univ, Dept Med, Hamilton, ON, Canada

[7] Boehringer Ingelheim GmbH & Co KG, Dept Med, Oslo, Norway

[8] Bellevue Hosp, Dept Vasc Pathol, St Etienne, France

[9] Municipal Hosp Friedrichstadt, Med Div 2, Dresden, Germany

[10] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

O-TH-033

引用

页码：731 / 732

页数：2

共 50 条

[1] Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
Schulman, Sam
Kearon, Clive
Kakkar, Ajay K.
Schellong, Sebastian
Eriksson, Henry
Baanstra, David
Kvamme, Anne Mathilde
Friedman, Jeffrey
Mismetti, Patrick
Goldhaber, Samuel Z.
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (08): : 709 - 718
[2] Dabigatran vs. placebo for extended maintenance therapy of venous thromboembolism
Schulman, S.
Baanstra, D.
Eriksson, H.
Goldhaber, S.
Kakkar, A.
Kearon, C.
Mismetti, P.
Schellong, S.
Schnee, J.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 22 - 22
[3] Dabigatran versus Warfarin for Venous Thromboembolism REPLY
Schulman, Sam
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (11): : 1050 - 1051
[4] Bleeding events with dabigatran or warfarin in patients with venous thromboembolism
Majeed, Ammar
Goldhaber, Samuel Z.
Kakkar, Ajay
Kearon, Clive
Eriksson, Henry
Kreuzer, Joerg
Feuring, Martin
Hantel, Stephan
Friedman, Jeffrey
Schellong, Sebastian
Schulman, Sam
THROMBOSIS AND HAEMOSTASIS, 2016, 115 (02) : 291 - 298
[5] Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer
Schulman, Sam
Goldhaber, Samuel Z.
Kearon, Clive
Kakkar, Ajay K.
Schellong, Sebastian
Eriksson, Henry
Hantel, Stefan
Feuring, Martin
Kreuzer, Joerg
THROMBOSIS AND HAEMOSTASIS, 2015, 114 (01) : 150 - 157
[6] Dabigatran Etexilate Versus Warfarin in the Treatment of Venous Thromboembolism
Schulman, Sam
Eriksson, Henry
Goldhaber, Samuel Z.
Kakkar, Ajay K.
Kearon, Clive
Mismetti, Patrick
Schellong, Sebastian M.
Baanstra, David
Schnee, Janet
BLOOD, 2009, 114 (22) : 3 - 3
[7] Dabigatran or warfarin in the treatment of acute venous thromboembolism in antiphospholipid syndrome
Schulman, S.
Goldhaber, S.
Kearon, C.
Kakkar, A. K.
Schellong, S.
Eriksson, H.
Schueler, E.
Feuring, M.
Kreutzer, J.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 985 - 985
[8] Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
Schulman, Sam
Kakkar, Ajay K.
Goldhaber, Samuel Z.
Schellong, Sebastian
Eriksson, Henry
Mismetti, Patrick
Christiansen, Anita Vedel
Friedman, Jeffrey
Le Maulf, Florence
Peter, Nuala
Kearon, Clive
CIRCULATION, 2014, 129 (07) : 764 - 772
[9] Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism.
Schulman, Sam
Kearon, Clive
Kakkar, Ajay K.
Mismetti, Patrick
Schellong, Sebastian
Eriksson, Henry
Baanstra, David
Schnee, Janet
Goldhaber, Samuel Z.
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (24): : 2342 - 2352
[10] Influence of cancer on the efficacy and safety of dabigatran vs. warfarin for the acute and extended treatment of venous thromboembolism
Schulman, S.
Eriksson, H.
Goldhaber, S. Z.
Kakkar, A.
Kearon, C.
Schellong, S.
Feuring, M.
Friedman, J.
Kreuzer, J.
THROMBOSIS RESEARCH, 2014, 133 : S221 - S221

← 1 2 3 4 5 →